Randomized clinical trial assessing the value of Beta-Blockers and Antiplatelet Agents in patients with Spontaneous Coronary Artery Dissectio

Phase 1

• Conditions: Spontaneous Coronary Artery Dissection; Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]

• Registration Number: EUCTR2021-001905-66-ES
• Lead Sponsor: Spanish Cardiology Society

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-06-23
• Last Update Posted: 12 July 2021

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: All
• Target Recruitment: 600

Inclusion Criteria

- Written informed consent
- Patients admitted for ACS or any other manifestation of myocardial ischemia
- Diagnosis of SCAD on a coronary angiography during index hospitalization
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 500
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 100

Exclusion Criteria

- Cardiogenic shock or severe hemodynamic instability
- Concomitant severe heart disease requiring surgical correction (in <2 years)
- Any major medical condition seriously limiting life expectancy (<2 years)
- Participation in another clinical trial

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified